Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer - A review focusing on open questions

International Journal of Colorectal Disease

Volumn 23, Issue 3, 2008, Pages 227-236

  Moser, Lutz ^a   Ritz, Jörg Peter ^a   Hinkelbein, Wolfgang ^a   Höcht, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Local recurrence; Quality of life; Radio chemotherapy; Radiotherapy; Rectal cancer; Sphincter preservation; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADJUVANT THERAPY; ANUS SPHINCTER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG INDICATION; HUMAN; LOW DRUG DOSE; OUTCOMES RESEARCH; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RECTUM CANCER; RECURRENCE RISK; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SHORT COURSE THERAPY; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ANTINEOPLASTIC AGENTS; DECISION MAKING; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 38649133302     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0419-3     Document Type: Review

References (113)

1. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M (2000) Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 284:1008-1015
2. Cedermark B, Johansson H, Rutqvist LE, Wilking N (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: A prospective randomized trial. Cancer 75:2269-2275
3. Gastrointestinal Tumor Study Group (1985) Prolongation of the disease free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465-1472
4. Kapiteijn E, Marijnen C, Colenbrander A, Klein Kranenbarg E, Steup W, van Krieken J, van Houwelingen J, Leer J, van de Velde C (1998) Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: A population-based study in the west Netherlands. Eur J Surg Oncol 24:528-535
5. Krook J, Moertel C, Gunderson L, Wieand H, Collins R, Beart R, Kubista T, Poon M, Meyers W, Mailliard J, Twito D, Morton R, Veeder M, Witzig T, Cha S, Vidyarthi S (1991) Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 324:709-715
6. Swedish Rectal Cancer Trial Group (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980-987 (Erratum (1997) N Engl J Med 336:1539)
7. Eriksen MT, Wibe A, Haffner J, Wiig JN, Norwegian Rectal Cancer Group (2007) Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156-167
8. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Conell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Jaffer AA, MacDonald JS, Willet CG, Goldberg RM (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: A pooled analysis. J Clin Oncol 22:1785-1796
9. Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990) Lowdose preoperative radiation postpones recurrences in operable rectal cancer: Results of a randomized multicenter trial in western Norway. Cancer 66:2286-2294
10. Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer: Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208:606-614
11. Goldberg PA, Nicholls RJ, Porter NH, Love S, Grimsey JE (1994) Long-term results of a randomised trial of short-course low dose adjuvant preoperative radiotherapy for rectal cancer: Reduction in local treatment failure. Eur J Cancer 30:1602-1606
12. Marsh PJ, James RD, Schofield PF (1994) Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: Results of a prospective, randomized trial. Dis Colon Rectum 37:1205-1214
13. Medical Research Council Rectal Cancer Working Party (1996) Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348:1605-1610
14. Reis Neto JA, Quilici FA, Reis JA Jr. (1989) A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma: A 10-year randomized trial. Dis Colon Rectum 32:702-710
15. Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomized trials. Lancet 358:1291-1304
16. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450
17. O'Connell M, Martenson J, Wieand H, Krook J, Macdonald J, Haller D, Mayer R, Gunderson L, Rich T (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502-507
18. Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson A, Haller DG, Mayer R, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542-3547
19. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradio-therapy for rectal cancer. N Engl J Med 351:1731-1740
20. Chiappa A, Biffi R, Zbar AP, Luca F, Crotti C, Bertani E, Biella F, Zampino G, Orecchia R, Fazio N, Venturino M, Crosta C, Pruneri GC, Grassi C, Andreoni B (2005) Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: A single unit experience, 1994-2003. Int J Colorectal Dis 20:221-230
21. Heald RJ (1980) Towards fewer colostomies - the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg 67:198-200
22. Hermanek P (1999) Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 42:559-562
23. Karanjia ND, Schache DJ, North WR, Heald RJ (1990) "Close shave" in anterior resection. Br J Surg 77:510-512
24. MacFarlane J, Ryall R, Heald R (1993) Mesorectal excision for rectal cancer. Lancet 341:457-460
25. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture. Br J Surg 71:12-16
26. Quirke P, Dixon M, Durdey P, Williams N (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 2:996-999
27. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B (2000) Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356:93-96
28. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92:225-229
29. Wibe A, Möller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Soreide O, Norwegian Rectal Cancer Group (2002) A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45:857-866
30. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327-334
31. Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz AB Jr, Gordon PH, Petrelli NJ, Deutsch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H, Fisher B (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388-396
32. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
33. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 357:497-504
34. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T, Ried T (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23:1826-1838
35. Greene FL, Stewart AK, Norton HJ (2004) New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: An analysis. J Clin Oncol 22:1778-1784
36. Junginger T, Hermanek P, Oberholzer K, Schmidberger H (2006) Rectal carcinoma: Is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication. Zentralbl Chir 131:275-284
37. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S (2004) Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19:518-524
38. Hansen MH, Kiaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B, Norwegian Rectal Cancer Group (2007) Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 94:113-118
39. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, Fearn PA, Kattan MW (2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98:715-717
40. MERCURY Study Group (2007) Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 243:132-139
41. Lippert H, Gastinger I (2006) Medical care of patients with rectal carcinoma in Germany. Dtsch Arztebl 103:A2704-2709
42. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G, Stephens R for the NCRI Colorectal Cancer Study Group and CR07 (2006) Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. Proc Am Soc Clin Oncol 2006:A3511
43. Quirke P, Sebag-Montefiore D, Steele R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G, Stephens R for the NCRI Colorectal Cancer Study Group and CR07 (2006) Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. Proc Am Soc Clin Oncol 2006:A3512
44. Fietkau R, Rödel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens H, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R, German rectal cancer study group (2007) Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: Results of study CAO/ARO/AIO-94
45. Glimelius B (2001) Pre- or postoperative radiotherapy in rectal cancer - more to learn? Radiother Oncol 61:1-5
46. Ooi B, Tjandra J, Green M (1999) Morbidities of adjuvant chemotherapy and radiotherapy for respectable rectal cancer: An overview. Dis Colon Rectum 42:403-418
47. Bosset JF, Colette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC for the EORTC Radiotherapy Group Trial 2291 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123
48. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without chemotherapy and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625
49. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, Bardet E, Pierart M, Briffaux A, EORTC Radiotherapy Group (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance - report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40:219-224
50. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, Kryj M, Oledzki J, Szmeja J, Sluszniak J, Serkies K, Kladny J, Pamucka M, Kukolowicz P (2004) Sphincter preservation following pre-operative radiotherapy for rectal cancer: Report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24
51. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryi M for the Polish Colorectal Study Group (2006) Long term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215-1223
52. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 17:2396-2402
53. Marijnen C, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW, Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after shortterm preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 20:817-826
54. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH, Pathology Review Committee and the Cooperative Clinical Investigators (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976-1984
55. Bosset JF, Calais G, Mineur L, Maigon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 23:5620-5627
56. Klautke G, Küchenmeister U, Foitzik T, Ludwig K, Prall F, Klar E, Fietkau R (2006) Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: Results from a phase I/II study. Br J Cancer 94:976-981
57. Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104
58. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, Barbet N, Atlan D, Adeleine P, Freyer G (2003) Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol. 21:1119-1124
59. Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ (2003) The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57:84-89
60. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107-112
61. Valentini V, Coco C, Cellini N, Picciocchi A, Rosetto ME, Mantini G, Marmiroli L, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M (1999) Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: Acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 45:1175-1184
62. Hartley A, Ho KF, McConkey C, Geh JI (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78:934-938
63. Glynne-Jones R, Anyamene N (2006) Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer? Int J Radiat Oncol Biol Phys 66:319-320
64. Hermanek P, Hermanek P, Hohenberger W, Klimpfinger M, Kockerling F, Papadopoulos T (2003) The pathological assessment of mesorectal excision: Implications for further treatment and quality management. Int J Colorectal Dis 18:335-341
65. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 194:131-136
66. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19-23
67. Rödel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688-8696
68. Fietkau R, Barten M, Klautke G, Klar E, Ludwig K, Thomas H, Brinckmann W, Friedrich A, Prall F, Hartung G, Kuchenmeister U, Kundt G (2006) Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49:1284-1292
69. Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maignon P, Radosevic-Jelic L, Pierart M, Calais G (2007) Patients with curative resections of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil based chemotherapy? A trial of the European organisation for research and treatment of cancer radiation oncology group. J Clin Oncol 25:4379-4386
70. Rasheed S, Guenther T, Talbot I, McDonald P, Northover J, Stirling J, Culver L, Glynne- Jones R, Padhani AR (2006) USPIO - enhanced rectal cancer specimen MRI: How well does it correlate with node identification at histopathology? Colorectal Dis 8:721
71. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668-674
72. Glynne-Jones R, Grainger J, Harrison M, Ostler P, Makris A (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: Should we be more cautious? Br J Cancer 94:363-371
73. Bujko K, Kepka L, Michalski W, Nowacki MP (2006) Does rectal cancer shrinkage induced by pre-operative radio (chemo)therapy increase the likelihood of anterior resection? A systematic review of randomized trials. Radiother Oncol 80:4-12
74. Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA (2003) Response to preoperative chemo-radiation increases the use of sphincter preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97:517-524
75. Hohenberger W, Merkel S, Matzel K, Bittorf B, Papadopoulos T Gohl J (2006) The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Colorectal Dis 8:23-33
76. Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, Cohen AM, Minsky BD (2001) Pre-operative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987-995
77. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, Deutsch M, Wickerham L, Fisher B, Wolmark N (1997) A clinical trial to evaluate the worth of pre- operative multi-modality therapy in patients with operable carcinoma of the rectum. A progress report of National Surgical Adjuvant Breast and bowel Project Protocol R-03. Dis Colon Rectum 40:131-139
78. Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW, Cooperative Investigators of the Dutch Colerectal Cancer Group (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311-1320
79. Bosset JF (2006) Distal rectal cancer: Sphincter-sparing is also a challenge for the radiation oncologist. Radiother Oncol 80:1-3
80. Moore HG, Riedel E, Minksy BD, Saltz L, Paty P, Wong D, Cohen AM, Guillem JG (2003) Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10:80-85
81. Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F (2005) Sphincter-saving resection for all rectal carcinomas. The end of the 2-cm distal rule. Ann Surg 241(3):465-469
82. Shirouzu K, Isomoto H, Kakegawa T (1995) Distal spread of rectal cancer and optimal distal margin of resection for sphincterpreserving surgery. Cancer 76:388-392
83. Valentini V, Glimelius B, Minsky BD, Van Cutsem E, Bartelink H, Beets-Tan RG, Gerard JP, Kosmidis P, Pahlman L, Picciocchi A, Quirke P, Tepper J, Tonato M, Van de Velde CJ, Cellini N, Latini P (2005) The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol 76:241-250
84. Wang Z, Zhou Z, Wang C, Zhao G, Chen Y, Gao H, Zheng X, Wang R, Chen D (2005) Microscopic spread of low rectal cancer in regions of the mesorectum: Detailed pathological assessment with whole-mount sections. Int J Colorectal Dis 20:231-237
85. Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: A study of distal intramural spread and of patients' survival. Br J Surg 70:150-154
86. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ, Pemberton JH, Wolff BG (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174:27-32
87. Gunderson L, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum: Clinicopathologic correlation and implications for adjuvant therapy. Cancer 34:1278-1292
88. Höcht S, Mann B, Germer CT, Siegmann A, Wiegel T, Buhr HJ, Hinkelbein W (2004) Pelvic sidewall involvement in recurrent rectal cancer. Int J Colorectal Dis 19:108-113
89. Hruby G, Barton M, Miles S, Carroll S, Nasser E, Stevens G (2003) Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: Implications for radiotherapy field design. Int J Radiat Oncol Biol Phys 55:138-143
90. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT (1998) Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer 61:1408-1416
91. Pilipshen S, Heilweil M, Quan S, Sternberg S, Enker W (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354-1362
92. Roels S, Duthoy W, Haustermans K, Penninckx F, Vandecaveye V, Boterberg T, De Neve W (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65:1129-1142
93. Baglan K, Frazier R, Yan D, Huang R, Martinez A, Robertson J (2002) The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52:176-183
94. Letschert J, Lebesque J, Aleman B, Bosset J, Horiot J, Bartelink H, Cionini L, Hamers J, Leer J, van Glabbeke M (1994) The volume effect in radiation related small-bowel complications: Results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal cancer. Radiother Oncol 32:116-123
95. Minsky BD, Conti J, Huang Y, Knopf K (1995) Relationship of acute gastrointestinal toxicity and volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13:1409-1416
96. Sauer R, Fietkau R, Wittekind C Martus P, Rödel C, Hohenberger W, Jatzko G, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R (2001) Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 177:173-181
97. Koda K, Saito N, Oda K, Takiguchi N, Sarashina H, Miyazaki M (2004) Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle and lower rectal cancers. Int J Colorect Dis 19:188-194
98. Kim JY, Kim DY, Kim TH, Park SY, Lee SB, Shin KH, Pyo H, Kim JY, Cho KH (2007) Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorect Dis 22:373-379
99. Peeters KCMJ, van de Velde CJH, Leer JWH, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients - a Dutch colorectal cancer group study. J Clin Oncol 23:6199-6206
100. Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, Szmeja J, Kladny J, Dymecki D, Wieczorek A, Pawlak M, Lesniak T, Kowalska T, Richter P, on behalf of the Polish Colorectal Study Group (2007) Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomized trial. Radiother Oncol 84:217-225
101. Dahlberg M, Glimelius B, Graf W, Pahlman L (1998) Pre-operative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 41:543-551
102. Gervaz P, Rotholtz N, Pisano M, Kaplan E, Secic M, Coucke P, Pikarsky A, Efron J, Weiss E, Wexner S (2001) Quantitative short-term study of anal sphincter function after chemoradiation for rectal cancer. Arch Surg 136:192-196
103. Nathanson D, Espat N, Nash G, D'Alessio M, Thaler H, Minsky BD, Enker W, Wong D, Guillem J, Cohen A, Paty P (2003) Evaluation of preoperative and postoperative radiotherapy on longterm functional results of straight coloanal anastomosis. Dis Colon Rectum 46:888-894
104. Rouanet P, Saint-Aubert B, Lemanski C, Senesse P, Gourgou S, Quenet F, Ycholu M, Kramar A, Dubois J (2002) Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation. Long-term oncologic and functional results. Dis Colon Rectum 45:305-315
105. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J (2001) Preoperative radiochemo-therapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 234:633-640
106. Guckenberger M, Flentje M (2006) Late small bowel toxicity after adjuvant treatment for rectal cancer. Int J Colorect Dis 21:209-220
107. Bakx R, Sprangers MA, Oort FJ, van Tets WF, Bemelman WA, Slors JF, van Lanschot JJ (2005) Development and validation of a colorectal functional outcome questionnaire. Int J Colorectal Dis 20:126-136
108. Pietsch AP, Fietkau R, Klautke G, Foitzik T, Klar E (2007) Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients. Int J Colorect Dis 22:1311-1317
109. Chorost M, Weber T, Lee R, Rodriguez-Bigas MA, Petrelli NJ (2000) Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg 179:271-274
110. Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM, Norwegian Rectal Cancer Group (2005) Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 31:735-742
111. Mannaerts G, Schijven M, Hendrikx A, Martijn H, Rutten HJ, Wiggers T (2001) Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 27:265-272
112. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 23:1847-1858
113. Temple L, Wong W, Minsky B (2003) The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol 13:469-477